Literature DB >> 26416647

Pioglitazone--when is a prescription drug safe?

Yoon Kong Loke1, Katharina Mattishent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26416647     DOI： 10.1038/nrurol.2015.237

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  The Safety of Prescription Drugs.

Authors:  Joshua M Sharfstein; Aaron S Kesselheim
Journal:  JAMA       Date:  2015-07-21       Impact factor: 56.272

2.  Evaluating Research on the Safety of Medical Therapies: The Responsibility of Journals to the Health of the Public.

Authors:  Phil B Fontanarosa; Howard Bauchner; Robert M Golub
Journal:  JAMA       Date:  2015-07-21       Impact factor: 56.272

3.  Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Authors:  James D Lewis; Laurel A Habel; Charles P Quesenberry; Brian L Strom; Tiffany Peng; Monique M Hedderson; Samantha F Ehrlich; Ronac Mamtani; Warren Bilker; David J Vaughn; Lisa Nessel; Stephen K Van Den Eeden; Assiamira Ferrara
Journal:  JAMA       Date:  2015-07-21       Impact factor: 56.272

4.  Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.

Authors:  Richard M Turner; Chun S Kwok; Chen Chen-Turner; Chinedu A Maduakor; Sonal Singh; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

5.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

6.  Thiazolidinediones and heart failure: a teleo-analysis.

Authors:  Sonal Singh; Yoon K Loke; Curt D Furberg
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

7.  Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

Authors:  James D Lewis; Assiamira Ferrara; Tiffany Peng; Monique Hedderson; Warren B Bilker; Charles P Quesenberry; David J Vaughn; Lisa Nessel; Joseph Selby; Brian L Strom
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

8.  Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.

Authors:  Daniel Levin; Samira Bell; Reijo Sund; Sirpa A Hartikainen; Jaakko Tuomilehto; Eero Pukkala; Ilmo Keskimäki; Ellena Badrick; Andrew G Renehan; Iain E Buchan; Samantha L Bowker; Jasjeet K Minhas-Sandhu; Zafar Zafari; Carlo Marra; Jeffrey A Johnson; Bruno H Stricker; Andrè G Uitterlinden; Albert Hofman; Rikje Ruiter; Catherine E de Keyser; Thomas M MacDonald; Sarah H Wild; Paul M McKeigue; Helen M Colhoun
Journal:  Diabetologia       Date:  2014-12-07       Impact factor: 10.122
  8 in total
  1 in total

Review 1.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.